Electrophysiological characterization of benzofuroindole-induced potentiation of large-conductance Ca2+-activated K+ channels

Molecular Pharmacology

Volumn 69, Issue 3, 2006, Pages 1007-1014

  Tal, Soo Ha ^a,b   Lim, Hyun Ho ^a   Ga, Eun Lee ^a   Kim, Yong Chul ^a   Park, Chul Seung ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 TRIFLUOROMETHYL 10H BENZO[4,5]FURO[3,2 B]INDOLE 1 CARBOXYLIC ACID; BENZOFURAN DERIVATIVE; CALCIUM; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BETA CHAIN; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTRIC POTENTIAL; ELECTROPHYSIOLOGY; HIPPOCAMPUS; HYPERPOLARIZATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

ANIMALS; CARBOXYLIC ACIDS; ELECTROPHYSIOLOGY; HIPPOCAMPUS; HUMANS; INDOLES; OOCYTES; POTASSIUM CHANNELS; POTASSIUM CHANNELS, CALCIUM-ACTIVATED; PROTEIN SUBUNITS; PYRAMIDAL CELLS; RATS; XENOPUS LAEVIS;

EID: 33644834764     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.016170     Document Type: Article

References (30)

1. Abdel-Hamid KM and Baimbridge KG (1997) The effects of artificial calcium buffers on calcium responses and glutamate-mediated excitotoxicity in cultured hippocampal neurons. Neuroscience 81:673-687.
2. Brenner R, Perez GJ, Bonev AD, Eckman DM, Kosek JC, Wiler SW, Patterson AJ, Nelson MT, and Aldrich RW (2000) Vasoregulation by the beta1 subunit of the calcium-activated potassium channel. Nature (Lond) 407:870-876.
3. Butera JA, Antane SA, Hirth B, Lennox JR, Sheldon JH, Norton NW, Warga D, and Argentieri TM (2001) Synthesis and potassium channel opening activity of substituted 10H-benzo[4,5]furo[3,2-b]indole-and 5,10-dihydro-indeno[1,2-b] indole-1-carboxylic acids. Bioorg Med Chem Lett 11:2093-2097.
4. Coghlan MJ, Carroll WA, and Gopalakrishnan M (2001) Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress. J Med Chem 44:1627-1653.
5. 2+ sensitivity. J Gen Physiol 116:411-432.
6. Dick GM, Hunter AC, and Sanders KM (2002) Ethylbromide tamoxifen, a membrane-impermeant antiestrogen, activates smooth muscle calcium-activated large-conductance potassium channels from the extracellular side. Mol Pharmacol 61:1105-1113.
7. Dick GM, Rossow CF, Smirnov S, Horowitz B, and Sanders KM (2001) Tamoxifen activates smooth muscle BK channels through the regulatory beta 1 subunit. J Biol Chem 276:34594-34599.
8. Giangiacomo KM, Kamassah A, Harris G, and McManus OB (1998) Mechanism of maxi-K channel activation by dehydrosoyasaponin-I. J Gen Physiol 112:485-501.
9. Gormemis AE, Ha TS, Im I, Jung KY, Lee JY, Park CS, and Kim YC (2005) Benzofuroindole analogues as potent BKCa channel openers. Chembiochem 6:1745-1748.
10. Hamil OP, Marty A, Neher E, Sakmann B, and Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflueg Arch Eur J Physiol 391:85-100.
11. + channel. Biophys J 86:2871-2882.
12. Ca channel variants differentially expressed in rat brain tissues. Eur J Biochem 267:910-918.
13. + channel α-subunit. Mol Pharmacol 62:836-846.
14. Jaggar JH, Porter VA, Lederer WJ, and Nelson MT (2000) Calcium sparks in smooth muscle. Am J Physiol 278:C235-C256.
15. Kaczorowski GJ and Garcia ML (1999) Pharmacology of voltage-gated and calciumactivated potassium channels. Curr Opin Chem Biol 3:448-458.
16. Lawson K (2000) Is there a role for potassium channel openers in neuronal ion channel disorders? Expert Opin Investig Drugs 9:2269-2280.
17. + channel determined by construction of multimeric cDNAs. Neuron 9:861-871.
18. Meera P, Wallner M, Jiang Z, and Toro L (1996) A calcium switch for the functional coupling between alpha (hslo) and beta subunits (KV,Ca beta) of maxi K channels. FEBS Lett 382:84-88.
19. + channel, a distinct member of voltage-dependent ion channels with seven N-terminal transmembrane segments (S0-S6) and extracellular N terminus and an intracellular (S9-S10) C terminus. Proc Natl Acad Sci USA 94:14066-14071.
20. 2+ transients and distribution of BK channels and ryanodine receptors in smooth muscle cells of guinea-pig vas deferens and urinary bladder. J Physiol (Lond) 534:313-326.
21. Patton C, Thomson S, and Epel D (2004) Some precautions in using chelators to buffer metals in biological solutions. Cell Calcium 35:427-431.
22. 2+ sensitivity of BK channels. J Gen Physiol 120:829-843.
23. Shieh CC, Coghlan M, Sullivan JP, and Gopalakrishnan M (2000) Potassium channels: molecular defects, diseases and therapeutic opportunities. Pharmacol Rev 52:557-594.
24. Starrett JE, Dworetzky SI, and Gibkoff VK (1996) Modulators of large-conductance calcium-activated potassium (BK) channels as potential therapeutic targets. Curr Pharm Des 2:413-428.
25. + channel superfamily. News Physiol Sci 13:112-117.
26. Valverde MA, Rojas P, Amigo J, Cosmelli D, Orio P, Bahamonde MI, Mann GE, Vergara C, and Latorre R (1999) Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit. Science (Wash DC) 285:1929-1931.
27. Vergara C, Latorre R, Marrion NV, and Adelman JP (1998) Calcium-activated potassium channels. Curr Opin Neurobiol 8:321-329.
28. + channels: a transmembrane β-subunit homolog. Proc Natl Acad Sci USA 96:4137-4142.
29. Weiger TM, Hermann A, and Levitan IB (2002) Modulation of calcium-activated potassium channels. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 188:79-87.
30. 2+-and voltage-dependent BK channels in adrenal chromaffin cells and rat insulinoma tumor cells. J Neurosci 19:5255-5264.